Fluorine-18-2-deoxy-2-fluoro-D-glucose positron emission tomography in colorectal cancer / 生物医学工程学杂志
Journal of Biomedical Engineering
; (6): 193-201, 2005.
Article
en Zh
| WPRIM
| ID: wpr-327102
Biblioteca responsable:
WPRO
ABSTRACT
Colorectal cancer is a leading cancer in many countries. The glucose metabolic activities of the tumor cells are higher than that of the normal cells. They could uptake much more 2-[18F] Fluoro-2-Deoxy-d-Glucose (18F-FDG), an analogue of glucose, than normal cells do. The physicians can search the lesions via 18F-FDG positron emission tomography (PET). 18F-FDG-PET has higher sensitivity and accuracy in diagnosing the primary lesion, recurrence, liver metastasis and extrahepatic metastasis of the colorectal cancer, compared with the conventional technique. The results of the 18F-FDG-PET often restage the colorectal cancer and even change the treatment plan as 18F-FDG-PET provides more information than traditional technique does. Also, it could be used to follow up the case of the colorectal cancer after operation, systematic chemotherapy and radiotherapy. The current review addresses the metabolism, the clinical application, the shortcomings and the future prospect.
Texto completo:
1
Base de datos:
WPRIM
Asunto principal:
Diagnóstico por Imagen
/
Neoplasias Colorrectales
/
Radiofármacos
/
Fluorodesoxiglucosa F18
/
Tomografía de Emisión de Positrones
Tipo de estudio:
Diagnostic_studies
Límite:
Humans
Idioma:
Zh
Revista:
Journal of Biomedical Engineering
Año:
2005
Tipo del documento:
Article